Six-Minute Walk Test as a Prognostic Tool in Stable Coronary Heart Disease: Data From the Heart and Soul Study | Acute Coronary Syndromes | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
1.
D’Agostino RB, Russell MW, Huse DM,  et al.  Primary and subsequent coronary risk appraisal: new results from the Framingham study [published correction appears in Am Heart J. 2002;143(1):21].  Am Heart J. 2000;139(2 pt 1):272-28110650300PubMedGoogle Scholar
2.
Vittinghoff E, Shlipak MG, Varosy PD,  et al; Heart and Estrogen/Progestin Replacement Study Research Group.  Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study.  Ann Intern Med. 2003;138(2):81-8912529088PubMedGoogle Scholar
3.
Shlipak MG, Ix JH, Bibbins-Domingo K, Lin F, Whooley MA. Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.  Am J Med. 2008;121(1):50-5718187073PubMedGoogle ScholarCrossref
4.
Vanhees L, Fagard R, Thijs L, Staessen J, Amery A. Prognostic significance of peak exercise capacity in patients with coronary artery disease.  J Am Coll Cardiol. 1994;23(2):358-3638294687PubMedGoogle ScholarCrossref
5.
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing.  N Engl J Med. 2002;346(11):793-80111893790PubMedGoogle ScholarCrossref
6.
Kavanagh T, Mertens DJ, Hamm LF,  et al.  Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation.  Circulation. 2002;106(6):666-67112163425PubMedGoogle ScholarCrossref
7.
Kavanagh T, Mertens DJ, Hamm LF,  et al.  Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation.  J Am Coll Cardiol. 2003;42(12):2139-214314680741PubMedGoogle ScholarCrossref
8.
Gibbons RJ, Balady GJ, Beasley JW,  et al.  ACC/AHA guidelines for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing).  J Am Coll Cardiol. 1997;30(1):260-3119207652PubMedGoogle ScholarCrossref
9.
Gibbons RJ, Balady GJ, Bricker JT,  et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).  ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).  Circulation. 2002;106(14):1883-189212356646PubMedGoogle ScholarCrossref
10.
Douglas PS, Khandheria B, Stainback RF,  et al; American College of Cardiology Foundation Appropriateness Criteria Task Force; American Society of Echocardiography; American College of Emergency Physicians; American Heart Association; American Society of Nuclear Cardiology; Society for Cardiovascular Angiography and Interventions; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance.  ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance: endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine.  Circulation. 2008;117(11):1478-149718316491PubMedGoogle ScholarCrossref
11.
Hendel RC, Berman DS, Di Carli MF,  et al; American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Nuclear Cardiology; American College of Radiology; American Heart Association; American Society of Echocardiography; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; Society of Nuclear Medicine.   ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine.  Circulation. 2009;119(22):e561-e58719451357PubMedGoogle ScholarCrossref
12.
Shah BR, Cowper PA, O’Brien SM,  et al.  Association between physician billing and cardiac stress testing patterns following coronary revascularization.  JAMA. 2011;306(18):1993-200022068991PubMedGoogle ScholarCrossref
13.
Rostagno C, Olivo G, Comeglio M,  et al.  Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation.  Eur J Heart Fail. 2003;5(3):247-25212798821PubMedGoogle ScholarCrossref
14.
Bittner V, Weiner DH, Yusuf S,  et al; SOLVD Investigators.  Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction.  JAMA. 1993;270(14):1702-17078411500PubMedGoogle ScholarCrossref
15.
Cahalin LP, Mathier MA, Semigran MJ, Dec GW, DiSalvo TG. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure.  Chest. 1996;110(2):325-3328697828PubMedGoogle ScholarCrossref
16.
Shah MR, Hasselblad V, Gheorghiade M,  et al.  Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy.  Am J Cardiol. 2001;88(9):987-99311703994PubMedGoogle ScholarCrossref
17.
Ingle L, Shelton RJ, Rigby AS, Nabb S, Clark AL, Cleland JG. The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure.  Eur Heart J. 2005;26(17):1742-175115831556PubMedGoogle ScholarCrossref
18.
Swiston JR, Johnson SR, Granton JT. Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature.  Respir Med. 2010;104(11):1588-160720810261PubMedGoogle ScholarCrossref
19.
Rasekaba T, Lee AL, Naughton MT, Williams TJ, Holland AE. The six-minute walk test: a useful metric for the cardiopulmonary patient.  Intern Med J. 2009;39(8):495-50119732197PubMedGoogle ScholarCrossref
20.
Whooley MA, de Jonge P, Vittinghoff E,  et al.  Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease.  JAMA. 2008;300(20):2379-238819033588PubMedGoogle ScholarCrossref
21.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories.  ATS statement: guidelines for the six-minute walk test.  Am J Respir Crit Care Med. 2002;166(1):111-11712091180PubMedGoogle Scholar
22.
Luepker RV, Apple FS, Christenson RH,  et al; AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute.  Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute.  Circulation. 2003;108(20):2543-254914610011PubMedGoogle ScholarCrossref
23.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure.  J Gen Intern Med. 2001;16(9):606-61311556941PubMedGoogle ScholarCrossref
24.
Levey AS, Stevens LA, Schmid CH,  et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration).  A new equation to estimate glomerular filtration rate.  Ann Intern Med. 2009;150(9):604-61219414839PubMedGoogle Scholar
25.
American College of Sports Medicine.  ACSM's Guidelines for Exercise Testing and Prescription. 6th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2000
26.
Schiller NB, Shah PM, Crawford M,  et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.  J Am Soc Echocardiogr. 1989;2(5):358-3672698218PubMedGoogle Scholar
27.
Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.  Stat Med. 2008;27(2):157-17217569110PubMedGoogle ScholarCrossref
28.
Pepe MS. Problems with risk reclassification methods for evaluating prediction models.  Am J Epidemiol. 2011;173(11):1327-133521555714PubMedGoogle ScholarCrossref
29.
Pepe MS, Kerr KF, Longton GM, Wang Z. UW Biostatistics Working Paper Series: testing for improvement in prediction model performance. CollectionofBiostatisticsResearchArchive. http://biostats.bepress.com/uwbiostat/paper379.Published2011. Accessed March 18, 2012
30.
Cacciatore F, Abete P, Mazzella F,  et al.  Six-minute walking test but not ejection fraction predicts mortality in elderly patients undergoing cardiac rehabilitation following coronary artery bypass grafting [published online September 20, 2011].  Eur J Cardiovasc Prev Rehabil21933832PubMedGoogle Scholar
31.
Guazzi M, Dickstein K, Vicenzi M, Arena R. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights.  Circ Heart Fail. 2009;2(6):549-55519919979PubMedGoogle ScholarCrossref
32.
Pollentier B, Irons SL, Benedetto CM,  et al.  Examination of the six-minute walk test to determine functional capacity in people with chronic heart failure: a systematic review.  Cardiopulm Phys Ther J. 2010;21(1):13-2120467515PubMedGoogle Scholar
33.
Boxer R, Kleppinger A, Ahmad A, Annis K, Hager D, Kenny A. The 6-minute walk is associated with frailty and predicts mortality in older adults with heart failure.  Congest Heart Fail. 2010;16(5):208-21320887617PubMedGoogle ScholarCrossref
34.
Daly CA, De Stavola B, Sendon JL,  et al; Euro Heart Survey Investigators.  Predicting prognosis in stable angina: results from the Euro Heart Survey of stable angina: prospective observational study.  BMJ. 2006;332(7536):262-26716415069PubMedGoogle ScholarCrossref
35.
Blankenberg S, McQueen MJ, Smieja M,  et al; HOPE Study Investigators.  Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.  Circulation. 2006;114(3):201-20816831981PubMedGoogle ScholarCrossref
36.
Omland T, de Lemos JA, Sabatine MS,  et al; Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators.  A sensitive cardiac troponin T assay in stable coronary artery disease.  N Engl J Med. 2009;361(26):2538-254719940289PubMedGoogle ScholarCrossref
37.
Centers for Medicare and Medicaid Services.  Medicare Physician Fee schedule search. https://www.cms.gov/apps/physician-fee-schedule/overview.aspx. Published 2012. Accessed March 18, 2012
38.
Heran BS, Chen JM, Ebrahim S,  et al.  Exercise-based cardiac rehabilitation for coronary heart disease.  Cochrane Database Syst Rev. 2011;(7):CD00180021735386PubMedGoogle Scholar
39.
Taylor RS, Brown A, Ebrahim S,  et al.  Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials.  Am J Med. 2004;116(10):682-69215121495PubMedGoogle ScholarCrossref
40.
Smith SC Jr, Benjamin EJ, Bonow RO,  et al; World Heart Federation and the Preventive Cardiovascular Nurses Association.  AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.  Circulation. 2011;124(22):2458-247322052934PubMedGoogle ScholarCrossref
41.
Balady GJ, Ades PA, Bittner VA,  et al; American Heart Association Science Advisory and Coordinating Committee.  Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association.  Circulation. 2011;124(25):2951-296022082676PubMedGoogle ScholarCrossref
42.
Suaya JA, Shepard DS, Normand SL, Ades PA, Prottas J, Stason WB. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery.  Circulation. 2007;116(15):1653-166217893274PubMedGoogle ScholarCrossref
Original Investigation
July 23, 2012

Six-Minute Walk Test as a Prognostic Tool in Stable Coronary Heart Disease: Data From the Heart and Soul Study

Author Affiliations

Author Affiliations: Departments of Medicine (Drs Beatty, Schiller, and Whooley) and Epidemiology and Biostatistics (Dr Whooley), University of California, San Francisco, and Veterans Affairs Medical Center, San Francisco (Dr Whooley).

Arch Intern Med. 2012;172(14):1096-1102. doi:10.1001/archinternmed.2012.2198
Abstract

Background The prognostic value of the 6-minute walk test (6MWT) in patients with stable coronary heart disease is unknown. We sought to determine whether the 6MWT predicted cardiovascular events in ambulatory patients with coronary heart disease.

Methods We measured 6MWT distance and treadmill exercise capacity in 556 outpatients with stable coronary heart disease from September 11, 2000, through December 20, 2002. Participants were followed up for a median of 8.0 years for cardiovascular events (heart failure, myocardial infarction, and death).

Results Cardiovascular events occurred in 218 of 556 participants (39.2%). Patients in the lowest quartile of 6MWT distance (87-419 m) had 4 times the rate of events as those in the highest quartile (544-837 m) (unadjusted hazard ratio, 4.29; 95% CI, 2.83-6.53; P < .001). Each SD decrease in 6MWT distance (104 m) was associated with a 55% higher rate of cardiovascular events (age-adjusted hazard ratio, 1.55; 95% CI, 1.35-1.78). After adjustment for traditional risk factors and cardiac disease severity measures (ejection fraction, inducible ischemia, diastolic dysfunction, amino-terminal portion of the prohormone of brain-type natriuretic peptide, and C-reactive protein), each SD decrease in 6MWT was associated with a 30% higher rate of cardiovascular events (hazard ratio, 1.30; 95% CI, 1.10-1.53). When added to traditional risk factors, the 6MWT resulted in category-free net reclassification improvement of 39% (95% CI, 19%-60%). The discriminative ability of the 6MWT was similar to that of treadmill exercise capacity for predicting cardiovascular events (C statistics both 0.72; P = .29).

Conclusions Distance walked on the 6MWT predicted cardiovascular events in patients with stable coronary heart disease. The addition of a simple 6MWT to traditional risk factors improved risk prediction and was comparable with treadmill exercise capacity.

×